Agilent Opens Global Manufacturing Facility for Life Sciences Instruments
Agilent Technologies announced the opening of its new life sciences instruments manufacturing facility in Singapore. The facility will produce the company's Liquid Chromatography/Mass Spectrometry (LC/MS) instruments for the global market.
"The opening of the LC/MS manufacturing facility marks a milestone in Agilent's continued investment in Singapore, which began in 1970," said Bill Sullivan, Agilent president and CEO. "Singapore is the ideal location for this facility as it will provide us with greater access to the life sciences instrument market in Asia. The new facility also will bring us closer to our customers, as the pharmaceutical and biopharmaceutical industries have become an important part of Singapore's overall economy and investment strategy."
Agilent's LC/MS instruments are widely used by pharmaceutical companies, from basic research through manufacturing and quality control. The instruments also serve customers in biotechnology, bioagriculture, food safety, chemical, petrochemical, forensics, homeland security, environmental, academic and government markets.
"I am pleased that Singapore will be an integral part of Agilent's global manufacturing network," said Mr. S Iswaran, Senior Minister of State for Trade & Industry and Education. "Life sciences companies can further tap Singapore as a base in Asia to drive business expansion and innovation for the region."
"This expansion marks a major achievement and positions Agilent to better meet rising worldwide customer demand for LC/MS instruments," said Nick Roelofs, president of Agilent's Life Sciences Group. "The new facility reflects the company's commitment to Singapore, its partners, and other stakeholders in the Asia Pacific region, as well as to the growing life sciences market worldwide."
In June 2009, the company announced the Agilent Automation Solutions facility, also in Singapore. The facility manufactures high-precision laboratory automation instruments.
"The new Agilent LC/MS manufacturing facility will attract top talent and enable the development of skilled engineers and chemists in Singapore as these are sophisticated high-end scientific instruments," said Soon-Chai Gooi, president of Agilent Technologies, Singapore and Malaysia. "The facility builds on Agilent Singapore's 40 years of innovation, experience and relationships with our partners and customers."
The Agilent LC/MS facility is located within the Agilent Life Sciences Group Order Fulfillment Center, located at its Yishun, Singapore, site. The center will be responsible for efficient management of the supply-chain network -- including planning, procurement, value-added engineering and logistics. The center ensures that the LC/MS facility is able to efficiently and effectively deliver configurable solutions to customers worldwide while maintaining Agilent's hallmark of quality.
Source: Agilent Technologies
More news from this company
- Agilent Opens Spectroscopy Technology Innovation Center (09/04/2013)
- Agilent to Acquire Dako for $2.2 Billion (05/25/2012)
- Agilent Technologies Awards 2011 Russell Varian Prize for Innovation in Nuclear Magnetic Resonance (10/04/2011)
- Agilent Technologies Acquires Lab901 to Expand Electrophoresis Portfolio for Molecular Biology Applications (03/08/2011)
- Agilent Technologies Instruments Selected by South African Doping Control Laboratory for 2010 World Cup (06/09/2010)